GLOW Peptide Blend for Research: BPC-157, TB-500, GHK-Cu
August 22, 2026
GLOW is a research blend of BPC-157, TB-500 and GHK-Cu. Its composition, how it differs from KLOW, and how a certificate should treat a three-component vial.
Read the article →Research Library
Analytical methods, compound overviews, and quality standards for peptide research — written for researchers who verify before they rely. All content concerns laboratory research use only.
NAD+ for Research: The Consumed Coenzyme
August 22, 2026
NAD+ is a dinucleotide coenzyme at the center of redox metabolism and the substrate of sirtuins, PARPs and CD38. Its research background, chemistry, and lot verification.
Read the article →IGF-1 LR3 for Research: The Cell-Culture Analogue of IGF-1
August 22, 2026
IGF-1 LR3 is an 83-residue analogue engineered to escape IGF-binding proteins in culture media. Why it exists, how it differs from native IGF-1, and lot verification.
Read the article →AOD-9604 for Research: The hGH C-Terminal Fragment
August 22, 2026
AOD-9604 is a synthetic 16-residue fragment of hGH (177-191) from the fragment-mapping era of hormone research. Its background, disulfide checkpoint, and lot quality.
Read the article →Kisspeptin-10 for Research: The Decapeptide Probe of KISS1R
August 22, 2026
Kisspeptin-10 is the minimal active fragment of the KISS1 peptide family, a standard probe in receptor research. Its two research tracks, structure, and lot quality.
Read the article →Sermorelin for Research: GHRH(1-29), the Reference Fragment
August 22, 2026
Sermorelin is GHRH(1-29) — the fragment that defined GHRH-receptor research and the baseline compound its analogues are measured against. Structure, literature, lot quality.
Read the article →Adamax for Research: The Stabilized Semax Analogue
August 22, 2026
Adamax is an adamantane-modified analogue of Semax with a thinner but growing research literature. How it differs from its parent, and what its certificate should show.
Read the article →5-Amino-1MQ for Research: The NNMT Inhibitor That Is Not a Peptide
August 22, 2026
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. Its research background in NAD+ and methylation metabolism, and what its certificate should show.
Read the article →PT-141 (Bremelanotide) for Research: Structure, Receptors, Lot Quality
August 22, 2026
PT-141 (bremelanotide) is a cyclic heptapeptide studied at melanocortin receptors. Its structure, its relationship to Melanotan II, and what its certificate should show.
Read the article →CJC-1295 + Ipamorelin Blend for Research: Two Compounds, One Vial
August 22, 2026
CJC-1295 and Ipamorelin are distinct molecules with different receptor targets. What each is, why the pairing recurs in research, and how a blend certificate should treat them.
Read the article →KLOW Peptide Blend for Research: The Four Components and Lot Quality
August 22, 2026
KLOW is a research blend of four peptides — BPC-157, TB-500, GHK-Cu and KPV. What each component is, why blends appear in research catalogs, and how to verify a lot.
Read the article →How to Vet a Research Peptide Supplier: The 7-Point Checklist
August 20, 2026
A practical, evidence-first checklist for evaluating any research peptide supplier: per-lot COAs, named laboratories, verifiable documents, and the red flags that matter.
Read the article →MOTS-c for Research: The Mitochondrial-Derived Peptide and Lot Quality
August 20, 2026
A research overview of MOTS-c: the 16-residue mitochondrial-derived peptide, its AMPK-focused metabolic literature, and how to verify lot purity.
Read the article →Selank for Research: The Tuftsin Analog, Its Anxiolytic Literature, and Lot Quality
August 20, 2026
A research overview of Selank: the tuftsin-derived heptapeptide, its GABA- and BDNF-focused preclinical literature, and how to verify lot purity.
Read the article →Semax for Research: The ACTH(4-10) Analog, Its Stability, and Lot Quality
August 20, 2026
A research overview of Semax: its heptapeptide structure, the BDNF-focused preclinical literature, and what to check on a certificate of analysis.
Read the article →Epithalon for Research: The Telomerase-Focused Tetrapeptide and Lot Quality
August 20, 2026
A research overview of Epithalon (epitalon, AEDG): its origin in pineal peptide research, the telomerase literature, and how to verify lot purity.
Read the article →CJC-1295 for Research: DAC vs No-DAC, Half-Life Chemistry, and Lot Quality
August 20, 2026
What separates CJC-1295 with DAC from the no-DAC form, how the Drug Affinity Complex changes stability, and what a quality lot looks like on paper.
Read the article →BPC-157 vs TB-500: How Researchers Distinguish the Two Repair-Pathway Peptides
August 19, 2026
BPC-157 and TB-500 are the two most-paired compounds in repair-pathway research — but they are structurally unrelated molecules with different mechanisms. A side-by-side researcher comparison.
Read the article →Tirzepatide for Research: The Dual GIP/GLP-1 Agonist and Its Quality Profile
August 19, 2026
Tirzepatide engages both GIP and GLP-1 receptor pathways — the first dual agonist to anchor research catalogs. Structure, handling notes, and lot-verification standards.
Read the article →Semaglutide for Research: The GLP-1 Analog, Its Lipidation, and Lot Quality
August 19, 2026
Semaglutide is the reference GLP-1 receptor research peptide. What the acylated analog is, why the fatty-acid modification matters for handling, and how researchers verify material.
Read the article →Verify before you rely.
Every compound in the catalog ships with a lot-specific certificate of analysis — ≥98% HPLC purity, mass-spec identity.
Browse the research catalog →